Jakob Kjellberg

Summary

Publications

  1. request reprint
    Kjellberg J, Jorgensen A, Vestergaard P, Ibsen R, Gerstoft F, Modi A. Cost and health care resource use associated with noncompliance with oral bisphosphonate therapy: an analysis using Danish health registries. Osteoporos Int. 2016;27:3535-3541 pubmed
    ..Approximately 30 % of Danish females aged 55 or older who take bisphosphonates are noncompliant. Noncompliance is significantly associated with increased health care resource use and cost. ..
  2. request reprint
    Kjellberg J. [Screening for cancer - economic consideration and cost-effectiveness]. Ugeskr Laeger. 2014;176: pubmed
    ..However, cost-effectiveness analyses are only as good as the clinical data and the results are sensitive to the chosen methods and perspective of the analysis. ..
  3. Jennum P, Pickering L, Christensen J, Ibsen R, Kjellberg J. Welfare cost of childhood- and adolescent-onset epilepsy: A controlled national study. Epilepsy Behav. 2016;61:72-77 pubmed publisher
    ..Children aged 0-5years incurred greater health-care costs than those aged 6-20years. Epilepsy has major socioeconomic consequences for the individual person with epilepsy and for society. ..
  4. Jennum P, Iversen H, Ibsen R, Kjellberg J. Cost of stroke: a controlled national study evaluating societal effects on patients and their partners. BMC Health Serv Res. 2015;15:466 pubmed publisher
    ..The negative social- and health-related status could be identified up to eleven years before the first diagnosis. Stroke has significant mortality, morbidity and socioeconomic consequences for patients, their partners and society. ..
  5. Jennum P, Sabers A, Christensen J, Ibsen R, Kjellberg J. Socioeconomic outcome of epilepsy surgery: A controlled national study. Seizure. 2016;42:52-56 pubmed publisher
  6. Jennum P, Pickering L, Thorstensen E, Ibsen R, Kjellberg J. Morbidity of childhood onset narcolepsy: a controlled national study. Sleep Med. 2017;29:13-17 pubmed publisher
    ..Before and after a diagnosis of narcolepsy in children, morbidity is more frequent in several domains, including metabolic, psychiatric, neurological and other diseases. ..
  7. Jennum P, Thorstensen E, Pickering L, Ibsen R, Kjellberg J. Morbidity and mortality of middle-aged and elderly narcoleptics. Sleep Med. 2017;36:23-28 pubmed publisher
    ..38 (1.12-1.69, p = 0.002) among those aged 60+ years. There are higher rates of morbidity in several disease domains before and after a diagnosis of narcolepsy. Elderly narcolepsy patients have higher mortality rates. ..
  8. Jennum P, Baandrup L, Ibsen R, Kjellberg J. Increased all-cause mortality with use of psychotropic medication in dementia patients and controls: A population-based register study. Eur Neuropsychopharmacol. 2015;25:1906-13 pubmed publisher
    ..Thus, the frequently reported increased mortality with antipsychotic drugs in dementia is not restricted to subjects with impaired cognition and is not restricted to only one class of psychotropic drugs. ..
  9. Jennum P, Sabers A, Christensen J, Ibsen R, Kjellberg J. Socioeconomic evaluation of vagus stimulation: A controlled national study. Seizure. 2016;42:15-19 pubmed publisher
    ..In fact, the number of people on disability pension increased during the period. VNS implantation in people with epilepsy is associated with reduced health care use, but not with occupational or social status. ..

More Information

Publications12

  1. Jennum P, Pickering L, Christensen J, Ibsen R, Kjellberg J. Morbidity and mortality of childhood- and adolescent-onset epilepsy: A controlled national study. Epilepsy Behav. 2017;66:80-85 pubmed publisher
    ..Epilepsy is associated with significant comorbidities and mortality including all health care domains, especially among persons who were young at the onset of epilepsy. ..
  2. Jennum P, Sabers A, Christensen J, Ibsen R, Kjellberg J. Welfare consequences for people with epilepsy and their partners: A matched nationwide study in Denmark. Seizure. 2017;49:17-24 pubmed publisher
    ..Epilepsy has major socioeconomic consequences for individual patients, their partners and society. ..
  3. Kjellberg J, Wolf R, Kruse M, Rasmussen S, Vestergaard J, Nielsen K, et al. Costs associated with adverse events among acute patients. BMC Health Serv Res. 2017;17:651 pubmed publisher
    ..Further research of specific types of AEs and the costs of preventing these types of AEs would improve the understanding of the relationship between adverse events and costs. ..